Ketone-Modified UiO-66 Membrane for Isoprene-Acetone Separation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing membranes for isoprene/acetone gas separation in human exhaled breath suffer from low selectivity and high gas penetration resistance, limiting their application in direct filtering of breath samples and causing interference in CRDS measurements.
Innovation Solution
A composite membrane is developed by modifying UiO-66-NH2 with glutaraldehyde and an amino compound containing a ketone group through a Schiff base reaction, followed by immobilization on a flat sheet membrane, enhancing the membrane's selectivity and reducing interference from acetone.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If traditional UiO-66-NH2 material is used for gas separation, then the membrane structure is simple and easy to manufacture, but the selectivity for isoprene/acetone separation is low due to limited active sites
Solution Approach 1:
The patent creates a composite membrane by combining UiO-66-NH2 MOF material with a polymer matrix (PVDF or PES). The MOF particles are dispersed within the polymer membrane, creating a mixed-matrix membrane that leverages both the structural stability of the polymer and the high selectivity of the MOF material for gas separation
Solution Approach 2:
The patent introduces functional groups (amino groups -NH2 and ketone groups C=O) at specific locations within the membrane structure. These groups are concentrated at the MOF-polymer interface and on the MOF surface, creating localized regions of high selectivity that enhance isoprene/acetone separation without requiring the entire membrane to be uniformly modified
2Manufacturing precision
If the base membrane is made dense to improve selectivity, then separation performance improves, but gas penetration resistance increases requiring external pressurization
Solution Approach 1:
The patent utilizes the inherent porous structure of UiO-66-NH2 MOF material with defined pore sizes (approximately 0.8 nm) that allow selective gas transport. The pores provide defined pathways for gas molecules while maintaining low resistance to flow, eliminating the need for dense membrane structures that would impede gas penetration
Solution Approach 2:
The patent optimizes the pore size and surface chemistry of the MOF particles to match the kinetic diameter and interaction characteristics of isoprene and acetone molecules. By tuning the MOF pore dimensions and functional group density, the membrane achieves high selectivity while maintaining high gas flux through the porous structure
3Reliability
If UiO-66-NH2 is used to adsorb polar gases, then CO2 and acetone adsorption is enhanced, but isoprene/acetone separation efficiency remains insufficient due to few active sites
Solution Approach 1:
The patent modifies the surface chemistry of UiO-66-NH2 by introducing ketone functional groups through reaction with glutaraldehyde. This transforms the surface from primarily amino-group dominated to having both amino and ketone groups, creating dual-functionality that enhances selectivity for isoprene/acetone separation while maintaining polar gas adsorption capability
Solution Approach 2:
The patent uses glutaraldehyde as a bridging agent that reacts with amino groups on the MOF surface to introduce ketone functional groups. The glutaraldehyde acts as an intermediary that connects the MOF structure to the new functional groups, creating a modified surface with enhanced separation performance
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified membrane significantly reduces measurement errors in CRDS tests and improves diagnostic accuracy by effectively separating isoprene and acetone, distinguishing between lung cancer patients and healthy individuals.
Implementation Method 1
a highly selective ultra-trace (ppbv level) isoprene/acetone gas separation membrane to minimize the interference of non-target component acetone on isoprene during spectral detection
Implementation Method 2
the glutaraldehyde contains two-CHO groups, which can bridge the —NH2 groups on the surface of UiO-66-NH2 and the amino compound containing ketone group, respectively, by Schiff base reaction
Implementation Method 3
The novel composite adsorbent is immobilized on the surface of commercial or homemade microporous base membranes using the vacuum filtration method
Data Source
AI summary
A composite membrane is provided/designed for separating isoprene, a biomarker for lung cancer in exhaled breath from acetone, along with a preparation method thereof. Glutaraldehyde and an amino compound containing a ketone group are used to modify aminofunctionalized metal-organic framework (UiO-66-NH2). Glutaraldehyde contains two aldehyde (—CHO) groups, which bridges the amino (—NH2) groups on the surface of UiO-66-NH2 and the amino compound containing the ketone group respectively, through Schiff base reaction. This process allows for the grafting ketone group-containing molecules onto UiO-66-NH2, resulting a novel composite adsorbent. Furthermore, the novel composite adsorbent is immobilized on the surface of a polymer-based flat sheet membrane using the vacuum filtration method, producing a modified composite membrane. The modified membrane demonstrates excellent separation performance of isoprene from acetone in human exhaled breath, which significantly reduces measurement errors caused by acetone in cavity ring-down spectroscopy (CRDS) tests.